← Open Payments lookup

SHANAE MAPP: Open Payments

NPI 1023532231 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$376 in 20 payments from 9 companies in 2025. Trend: 2023 $61 · 2024 $764 · 2025 $376

Food & beverage: $376
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.3$66
Axsome Therapeutics, Inc.3$61
ABBVIE INC.3$59
Otsuka America Pharmaceutical, Inc.2$40
Noven Therapeutics, LLC2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$34
Janssen Pharmaceuticals, Inc2$33
Neurocrine BioSciences, Inc.2$30
E.R. Squibb & Sons, L.L.C.1$16

Products named: UZEDY, Auvelity, VRAYLAR, ABILIFY ASIMTUFII, Xelstrym, CAPLYTA, INGREZZA, SPRAVATO.

Industry payments across CA — which companies pay providers there.